Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 519 * ! | Wed, 8/7/2013, 10:30 AM - 12:20 PM | CC-510b | |
| Consistency of Treatment Effects in Multi-Regional Clinical Trials — Topic Contributed Papers | |||
| Biopharmaceutical Section , Mental Health Statistics Section , Biometrics Section | |||
| Organizer(s): Gang Li, Johnson & Johnson | |||
| Chair(s): Gang Li, Johnson & Johnson | |||
| 10:35 AM | Sample Size Consideration for Treatment Effect Consistency Assessment in Multi-Regional Clinical Trials and Bridging Studies — Hui Quan, Sanofi ; Gang Li, Johnson & Johnson ; Josh Chen, Merck ; Yue Shentu, Merck | ||
| 10:55 AM | Design Consideration for Simultaneous Global Drug Development Program — Gang Chen, J&J | ||
| 11:15 AM | Beauty Can Be in the Eye of the Beholder, but Consistency Should Not — Bruce Binkowitz, Merck & Co Inc | ||
| 11:35 AM | Statistical Considerations for Bridging/Multi-Regional Trials — Shein-Chung Chow, Duke University | ||
| 11:55 AM | Discussant: Jen-pei Liu, National Taiwan University | ||
| 12:15 PM | Floor Discussion | ||
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.